These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2936661)

  • 21. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midazolam for intramuscular premedication: dose-effect relationships compared to diazepam, fentanyl and fentanyl-droperidol in a placebo controlled study.
    Van de Velde A; Camu F; Claeys MA
    Acta Anaesthesiol Belg; 1986; 37(2):127-36. PubMed ID: 2875594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects.
    Pentikäinen PJ; Välisalmi L; Himberg JJ; Crevoisier C
    J Clin Pharmacol; 1989 Mar; 29(3):272-7. PubMed ID: 2723115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis.
    Wensing G; Hoffmann K; Heidemann HT
    Z Gastroenterol; 1993 Jan; 31(1):15-9. PubMed ID: 8447150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and the sedative effect of midazolam.
    Kanto J; Allonen H
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):460-3. PubMed ID: 6138314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranitidine disposition in severe hepatic cirrhosis.
    Gonzalez-Martin G; Paulos C; Veloso B; Chesta J; Novoa X; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):139-42. PubMed ID: 3557740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midazolam.
    Med Lett Drugs Ther; 1986 Aug; 28(719):73-4. PubMed ID: 2942752
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of plasma proteins on the onset of hypnotic action of intravenous midazolam.
    Halliday NJ; Dundee JW; Collier PS; Loughran PG; Harper KW
    Anaesthesia; 1985 Aug; 40(8):763-6. PubMed ID: 2931035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma concentrations and sedation scores after nebulized and intranasal midazolam in healthy volunteers.
    McCormick AS; Thomas VL; Berry D; Thomas PW
    Br J Anaesth; 2008 May; 100(5):631-6. PubMed ID: 18385262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
    Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of diazepam and midazolam when used for sedation following cardiopulmonary bypass.
    Lowry KG; Dundee JW; McClean E; Lyons SM; Carson IW; Orr IA
    Br J Anaesth; 1985 Sep; 57(9):883-5. PubMed ID: 3161529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quinidine disposition in relation to antipyrine elimination and debrisoquine phenotype in alcoholic patients with and without cirrhosis.
    Debruyne D; Gram LF; Grollier G; Camsonne R; Agron L; Dao MT; Lacotte J; Bigot MC; Moulin M
    Int J Clin Pharmacol Res; 1989; 9(5):319-25. PubMed ID: 2625371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209).
    Guittet C; Manso M; Burton I; Granier LA; Marçon F
    Pharm Res; 2017 Sep; 34(9):1840-1848. PubMed ID: 28577272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosis.
    Larrey D; Lebrec D; Bercoff E; Pessayre D
    Clin Sci (Lond); 1983 Aug; 65(2):203-5. PubMed ID: 6602683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of midazolam premedication on mental and psychomotor recovery in geriatric patients undergoing brief surgical procedures.
    Fredman B; Lahav M; Zohar E; Golod M; Paruta I; Jedeikin R
    Anesth Analg; 1999 Nov; 89(5):1161-6. PubMed ID: 10553827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colchicine clearance is impaired in alcoholic cirrhosis.
    Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
    Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between plasma levels and psychological effects of benzodiazepines.
    Ziegler G; Ludwig L; Klotz U
    Pharmacopsychiatria; 1983 May; 16(3):71-6. PubMed ID: 6136997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired elimination of caffeine in cirrhosis.
    Desmond PV; Patwardhan RV; Johnson RF; Schenker S
    Dig Dis Sci; 1980 Mar; 25(3):193-7. PubMed ID: 7371463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of midazolam in conjunction with alcohol on sleep, psychomotor performance and car driving ability.
    Hindmarch I; Subhan Z
    Int J Clin Pharmacol Res; 1983; 3(5):323-9. PubMed ID: 6678826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.